Artículos de revistas
Medicação de alto custo para portador de sofrimento psíquico: Um estudo preliminar dos custos
Fecha
2007-01-01Registro en:
Acta Scientiarum - Health Sciences, v. 29, n. 1, p. 19-23, 2007.
1679-9291
10.4025/actascihealthsci.v29i1.118
2-s2.0-55049109893
2-s2.0-55049109893.pdf
7671075123602579
7945918805559032
6407308564031371
Autor
Faculdade de Medicina de Marília (FAMEMA)
Universidade Estadual Paulista (Unesp)
Institución
Resumen
The present work aims to raise the costs of high-cost drugs used to treat patients of Refractory Schizophrenia in ambulatory unit. The study was carried out in the Psychosocial Support Center, which treated 33 patients with these medications, during the period of June, 2005 to May, 2006. Data analysis disclosed that the mostly used drugs to treat the carriers of Refractory Schizophrenia were: clozapina and risperidona. It was observed that the treatment with olanzapina is more expensive than that with risperidona. The study concluded that the analysis of the consumption and costs of drugs of high cost is necessary to subside better management of the expenses and new investments in the service. Moreover, the necessity of more studies in the area was also identified to contribute with the control of costs.